Docoh
Loading...

BLU Bellus Health

Filed: 8 Dec 20, 7:00am

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
  
 
FORM 6-K
 
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
 
For the month of December 2020
 
 
Commission File Number:  001-39034
 
 
BELLUS HEALTH INC.

(Name of registrant)



275 Armand-Frappier Blvd.
Laval, Québec
H7V 4A7
Canada

(Address of principal executive offices)

 

 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 
 ☐    Form 20-F
 ☒    Form 40-F
 
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
  


SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 
 BELLUS Health Inc. 
   
   
   
    
Date: December 8, 2020By:/s/ Ramzi Benamar 
  
Name:  Ramzi Benamar
 
  
Title:      Chief Financial Officer
 
    


Form 6-K Exhibit Index
 
Exhibit Number Document Description